A new once-a-month HIV prevention pill is moving into the final stage of testing. But early South African uptake data of the ...
Reverse transcription polymerase chain reaction (RTPCR) is a technique to detect or quantify RNA. It uses a reverse transcriptase enzyme to convert RNA to DNA, followed by PCR to amplify the DNA.
Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...
A two-drug regimen was noninferior to a three-drug regimen as initial antiretroviral therapy (ART) for adults with HIV, a phase IIIb trial showed. At week 48, an HIV-1 RNA level of less than 50 copies ...
HIV treatment has progressed significantly since the 1980s. ART enables viral suppression and prevents transmission, but HIV ...
Merck enters new agreement with ADAP Crisis Task Force to improve access and care for people living with HIV: Rahway, New Jersey Wednesday, July 1, 2026, 14:00 Hrs [IST] Merck, kn ...
On Tuesday, the White House Office of Science and Technology Policy (OSTP) released a report entitled “Science: A New Golden ...
Gilead Sciences and MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral load suppression in ...
Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...
Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about ...
Bile acid metabolism suppression was linked to colorectal cancer prognosis and a 15 gene signature predicted overall survival ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results